Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials

被引：0
|
作者：
Lars-Erik Kristensen [1 ]
Dennis McGonagle [2 ]
Martin Rudwaleit [3 ]
Hideto Kameda [4 ]
Peter Adler Würtzen [5 ]
Marcus Ngantcha [5 ]
Thorsten Holzkämper [5 ]
Josef Smolen [6 ]
机构：
[1] The Parker Institute,Rheumatology
[2] Bispebjerg and Frederiksberg Hospital,Department of Internal Medicine
[3] Leeds Institute of Rheumatic and Musculoskeletal Medicine,Department of Rheumatology
[4] University of Bielefeld,undefined
[5] Toho University,undefined
[6] Eli Lilly and Company,undefined
[7] Vienna General Hospital,undefined
[8] University of Vienna,undefined
来源：
Rheumatology and Therapy | 2025年 / 12卷 / 2期
关键词：
Psoriatic arthritis; Enthesitis; Axial disease; Dactylitis; Peripheral arthritis; Skin psoriasis; Nail psoriasis; Health-related quality of life;
D O I：
10.1007/s40744-025-00748-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 395
页数：14
相关论文
共 50 条
  • [1] ASSOCIATION OF THE IMPROVEMENT OF SYNOVITIS AND ENTHESITIS WITH QUALITY OF LIFE/PATIENT REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH IXEKIZUMAB
    McGonagle, Dennis
    Kristensen, Lars-Erik
    Rudwaleit, Martin
    Kameda, Hideto
    Holzkaemper, Thorsten
    El Baou, Celine
    Smolen, Josef
    RHEUMATOLOGY, 2022, 61
  • [2] Sustained improvements in patient-reported outcomes in psoriatic arthritis patients treated with etanercept
    Mease, P
    Gottlieb, A
    Woolley, JM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P2 - P2
  • [3] Association of the Improvement of Synovitis and Enthesitis with Quality of Life/Patient Reported Outcomes in Patients with PsA Treated with Ixekizumab
    Kristensen, Lars Erik
    McGonagle, Dennis
    Rudwaleit, Martin
    Kameda, Hideto
    Holzkaemper, Thorsten
    El Baou, Celine
    Smolen, Josef
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3722 - 3724
  • [4] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Proton Rahman
    Iain B. McInnes
    Atul Deodhar
    Georg Schett
    Phillip J. Mease
    May Shawi
    Daniel J. Cua
    Jonathan P. Sherlock
    Alexa P. Kollmeier
    Xie L. Xu
    Shihong Sheng
    Christopher T. Ritchlin
    Dennis McGonagle
    Clinical Rheumatology, 2024, 43 : 1591 - 1604
  • [5] Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis
    Rahman, Proton
    Mcinnes, Iain B.
    Deodhar, Atul
    Schett, Georg
    Mease, Phillip J.
    Shawi, May
    Cua, Daniel J.
    Sherlock, Jonathan P.
    Kollmeier, Alexa P.
    Xu, Xie L.
    Sheng, Shihong
    Ritchlin, Christopher T.
    McGonagle, Dennis
    CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1591 - 1604
  • [6] RAPID AND SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH IXEKIZUMAB IN BIOLOGIC-NAIVE AND TNF-INADEQUATE RESPONDER PATIENTS WITH PSORIATIC ARTHRITIS
    Tahir, Hasan
    Nassab, Mani Haschemi
    Bradley, Andrew
    Pum, Georg
    Van Beneden, Katrien
    RHEUMATOLOGY, 2019, 58
  • [7] Rapid and sustained improvements in patient-reported outcomes with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis
    Hasan, Tahir
    Haschemi, Nassab Mani
    Andrew, Bradley
    Georg, Pum
    Katrien, Van Beneden
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [8] Patient-Reported Outcomes in Psoriatic Arthritis
    Orbai, Ana-Maria
    Ogdie, Alexis
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (02) : 265 - +
  • [9] Changes in Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Ixekizumab in a Real-World US Cohort
    Tillett, William
    Birt, Julie
    Cavanaugh, Cristi
    Jung, Yoojin
    Vadhariya, Aisha
    Ross, Sarah
    Paulus, Jessica
    Sprabery, Aubrey
    Lubrano, Ennio
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 750 - 752
  • [10] CHANGES IN DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH IXEKIZUMAB IN A REAL-WORLD US COHORT
    Birt, J.
    Tillett, W.
    Cavanaugh, C.
    Jung, Y.
    Vadhariya, A.
    Ross, S.
    Paulus, J.
    Sprabery, A. T.
    Lubrano, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 851 - 852
12345